Plasma and intracellular exposure to ganciclovir in adult renal transplant recipients: is there an association with haematological toxicity?

Liquid chromatography tandem mass spectrometry quantitation of intracellular concentrations of ganciclovir and its phosphorylated forms

(2015) Pierre-André Billat et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients

(2014) Heather E. Vezina et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R

(2012) Michael N. Neely et al.   THERAPEUTIC DRUG MONITORING

Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study

(2010) Oriol Manuel et al.   CLINICAL TRANSPLANTATION

Population Pharmacokinetics of Ganciclovir after Intravenous Ganciclovir and Oral Valganciclovir Administration in Solid Organ Transplant Patients Infected with Cytomegalovirus

(2009) A. Caldes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Valganciclovir in Adult Solid Organ Transplant Recipients

(2009) Nancy Perrottet et al.   CLINICAL PHARMACOKINETICS

The Human Multidrug Resistance Protein 4 (MRP4, ABCC4): Functional Analysis of a Highly Polymorphic Gene

(2008) N. Abla et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS